Glutamate metabolism in HIV-infected macrophages: implications for the CNS

Area of Science:

• Neuroscience
• Immunology
• Virology

Background:

• Central nervous system disorders are a common complication of human immunodeficiency virus (HIV) infection, often leading to dementia and death.
• These disorders are linked to inflammatory macrophagic activation and glutamate-mediated excitotoxicity.
• Recent research suggests potential neuroprotective roles for macrophage activation via glutamate transporters and glutamine synthetase.

Purpose of the Study:

• To investigate how HIV infection and macrophage activation influence glutamate metabolism within macrophages.
• To assess the expression of glutamate transporters and glutamine synthetase in HIV-infected macrophages.
• To determine if inflammatory mediators directly affect macrophage glutamate metabolism in the context of HIV.

Main Methods:

• Assessed glutamate transporter expression and uptake in macrophages during HIV infection.
• Measured excitatory amino acid transporter-2 (EAAT-2) gene expression and glutamine synthetase activity.
• Quantified EAAT-1 and EAAT-2 gene expression and glutamate uptake in differentially activated macrophages.

Main Results:

• HIV infection partially decreased glutamate transport but significantly increased EAAT-2 gene expression in macrophages.
• Functional expression of glutamine synthetase was observed in macrophages for the first time, repressed during HIV production.
• Macrophage glutamate transport was less affected by HIV than in astrocytes, and effects were independent of inflammatory mediators.

Conclusions:

• Macrophages express functional glutamate transporters (EAATs) and glutamine synthetase, suggesting a role in neuroprotection against glutamate excitotoxicity in HIV encephalitis.
• Glutamate metabolism in activated macrophages is modulated by HIV infection and inflammation.
• Macrophage glutamate metabolism represents a potential therapeutic target for HIV-related central nervous system disorders.